Abstract
Introduction
Medicines cause over 1700 preventable deaths annually in England. Coroners’ Prevention of Future Death reports (PFDs) are produced in response to preventable deaths to facilitate change. The information in PFDs may help reduce medicine-related preventable deaths.
Objectives
We aimed to identify medicine-related deaths in coroners’ reports and to explore concerns to prevent future deaths.
Methods
We carried out a retrospective case series of PFDs across England and Wales, dated between 1 July, 2013 and 23 February, 2022, collected from the UK’s Courts and Tribunals Judiciary website using web scraping, generating an openly available database: https://preventabledeathstracker.net/. We used descriptive techniques and content analysis to assess the main outcome criteria: the proportion of PFDs in which coroners reported that a therapeutic medicine or drug of abuse had caused or contributed to a death; the characteristics of included PFDs; coroners’ concerns; the recipients of PFDs; and the timeliness of their responses.
Results
There were 704 PFDs (18%; 716 deaths) that involved medicines, representing an estimated 19,740 years of life lost (average of 50 years lost per death). Opioids (22%), antidepressants (9.7%), and hypnotics (9.2%) were the most common drugs involved. Coroners expressed 1249 concerns, primarily around the major themes of patient safety (29%) and communication (26%), including minor themes of failures of monitoring (10%) and poor communication between organizations (7.5%). Most expected responses to PFDs (51%; 630/1245) were not reported on the UK’s Courts and Tribunals Judiciary website.
Conclusions
One in five coroner-reported preventable deaths involved medicines. Addressing coroners’ concerns, including problems with patient safety and communication, should reduce harms from medicines. Despite concerns being raised repeatedly, half of the PFD recipients failed to respond, suggesting that lessons are not generally learned. The rich information in PFDs should be used to foster a learning environment in clinical practice that may help reduce preventable deaths.
Clinical Trial Registration
Similar content being viewed by others
References
Taylor S, Annand F, Burkinshaw P, Greaves F, Kelleher M, Knight J, et al. Dependence and withdrawal associated with some prescribed medicines: an evidence review. London: Public Health England; 2019.
Kingston A, Robinson L, Booth H, Knapp M, Jagger C, Adelaja B, et al. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model. Age Ageing. 2018;47:374–80. https://doi.org/10.1093/ageing/afx201.
Lichtenberg FR. How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000–2013. Int Health. 2019;11:403–16. https://doi.org/10.1093/inthealth/ihz003.
Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol. 2018;84:542–52. https://doi.org/10.1111/bcp.13471.
Pardo Cabello AJ, del Pozo GE, Gómez Jiménez FJ, Mota Rodríguez C, Luna Del Castillo JDD, Puche CE. Drug-related mortality among inpatients: a retrospective observational study. Eur J Clin Pharmacol. 2016;72:731–6. https://doi.org/10.1007/s00228-016-2026-0.
Elliott RA, Camacho E, Jankovic D, Sculpher MJ, Faria R. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2020;30:96–105. https://doi.org/10.1136/bmjqs-2019-010206.
Coroners and Justice Act 2009. Statute Law Database; 2009.
The Coroners Rules 1984. 552 United Kingdom. 1 July, 1984. https://www.legislation.gov.uk/uksi/1984/552/article/6/made. Accessed 28 Jan 2023.
The Coroners (Investigations) Regulations 2013. Queen’s Printer of Acts of Parliament; 2013.
Ferner RE, Easton C, Cox AR. Deaths from medicines: a systematic analysis of coroners’ reports to prevent future deaths. Drug Saf. 2018;41:103–10. https://doi.org/10.1007/s40264-017-0588-0.
Anis A, Heneghan C, Aronson JK, DeVito NJ, Richards GC. Deaths from cardiovascular disease involving anticoagulants: a systematic synthesis of coroners’ case reports. BJGP Open. 2022;6(1):BJGPO.2021.0150.
Aronson JK, Ferner RE, Richards GC. Deaths attributed to the use of medications purchased online. BMJ Evid Based Med. 2022;27:60–4. https://doi.org/10.1136/bmjebm-2021-111759.
France HS, Richards GC, Aronson JK, Ferner R, Cox AR, Heneghan C. Pre-registration of Preventable deaths involving medicines and misused drugs: a systematic analysis of coroners’ case reports in England and Wales 2019–2021. OSF; 2021. https://doi.org/10.17605/OSF.IO/TX3CS. Accessed 11 Sep 2022.
Prevention of Future Deaths | Subjects | Courts and Tribunals Judiciary. 2022. https://www.judiciary.uk/subject/prevention-of-future-deaths/. Accessed 2 Feb 2022.
DeVito NJ, Richards GC, Inglesby P. How we learnt to stop worrying and love web scraping. Nature. 2020;585:621–2. https://doi.org/10.1038/d41586-020-02558-0.
Richards GC. Preventable deaths tracker. https://preventabledeathstracker.net/the-database/. Accessed 28 Jun 2021.
Joint Formulary Committee. British National Formulary. 82nd ed. BMJ Group, editor. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2021.
IUPHAR. IUPHAR/BPS guide to pharmacology. 2021. https://www.guidetopharmacology.org/. Accessed 28 Sep 2021.
Misuse of Drugs Act 1971. Statute Law Database; 1971.
Buxton J. Life expectancy in the UK: 2018 to 2020. Office for National Statistics. 2021.
World Health Organization. Years of life lost (YLL) (per 100 000 population). Global Health Observatory. 2006. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4427. Accessed 25 Nov 2021.
Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88. https://doi.org/10.1177/1049732305276687.
Leary A, Bushe D, Oldman C, Lawler J, Punshon G. A thematic analysis of the prevention of future deaths reports in healthcare from HM coroners in England and Wales 2016–2019. J Patient Saf Risk Manag. 2021;26:14–21. https://doi.org/10.1177/2516043521992651.
Richards GC. Deaths from cardiovascular disease involving anticoagulants. Github; 2021.
France HS, Richards GC. OSF: preventable deaths involving medicines and misused drugs: a systematic analysis of coroners’ case reports in England and Wales 2013-2021. OSF; 2021. https://osf.io/wq7g5/. Accessed 15 Feb 2022.
France H. Pandemics, pharmacology, and preventable deaths. London: Pharmacology Matters, British Pharmacological Society; 2022.
Semple L, Gamblin N. Avoidable mortality in Great Britain: 2020. 2022.
Walters S. Coroners statistics 2019: England and Wales. 2019. https://www.gov.uk/government/statistics/coroners-statistics-2019/coroners-statistics-2019-england-and-wales. Accessed 28 Jan 2023.
Coronial Services of New Zealand. Coronial Services of New Zealand Regulations. 2022. https://coronialservices.justice.govt.nz/coronial-services/. Accessed 3 Feb 2022.
Coroners Court of Victoria. Coroners Court of Victoria Regulations. https://www.coronerscourt.vic.gov.au/. Accessed 3 Feb 2022.
State Coroner’s Court of New South Wales. Coroners Court of New South Wales Regulations. 2022. https://www.coroners.nsw.gov.au/. Accessed 3 Feb 2022.
Office of the Chief Coroner. Ontario Ministry of Community Services and Correctional Services. Coroners Act 1990. 37 Canada. 19 April, 1990. https://www.ontario.ca/laws/statute/90c37. Accessed 28 Jan 2023.
Swift B, Heneghan C, Aronson J, Howard D, Richards GC. Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners’ reports during the COVID-19 pandemic. BMJ Evid Based Med. 2022;27(5):296–304. https://doi.org/10.1136/bmjebm-2021-111834.
Ferner RE, Ahmad T, Babatunde Z, Cox AR. Preventing future deaths from medicines: responses to coroners’ concerns in England and Wales. Drug Saf. 2019;42:445–51. https://doi.org/10.1007/s40264-018-0738-z.
Aaronson EL, Brown D, Benzer T, Natsui S, Mort E. Incident reporting in emergency medicine: a thematic analysis of events. J Patient Saf. 2019;15:E60–3. https://doi.org/10.1097/PTS.0000000000000399.
Mclean M, Roach J, Armitage R. Local variations in reporting deaths to the coroner in England and Wales: a postcode lottery? J Clin Pathol. 2013;66:933–6. https://doi.org/10.1136/jclinpath-2013-201640.
Fox AW, Jacobson J. How well do Regulation 28 reports serve future public health and safety? Med Sci Law. 2021;61:186–92. https://doi.org/10.1177/0025802420987431.
King R, Benbow EW. Are the recommendations in coronial prevention of future death (PFD) reports realistic and achievable? Med Leg J. 2022;90:27–31. https://doi.org/10.1177/00258172211059905.
Richards GC, Aronson JK, Heneghan C. Coroners’ concerns to prevent harms: a series of coroners’ case reports to serve patient safety and educate the public, clinicians and policy-makers. BMJ Evid Based Med. 2021;26:37–8. https://doi.org/10.1136/bmjebm-2020-111567.
Richards GC, Anthony G, Aronson JK, Heneghan C, Goldacre B. Preventable suicides: a systematic analysis of coroners’ prevent future death reports in England and Wales. OSF; 2020. https://osf.io/ad4up/. Accessed 14 Jun 2021.
Richards GC, Aronson JK, Ferner RE, Cox AR, Heneghan C, Goldacre B, et al. Preventable opioid-related deaths: a systematic analysis of coroners’ reports. OSF; 2019. https://osf.io/ecz4r/. Accessed 14 Jun 2021.
Karolina Bilip M, Richards GC. Emollients and smoking: a fire hazard that could be prevented to reduce future deaths. BMJ Evid Based Med. 2021;26:131–4. https://doi.org/10.1136/bmjebm-2020-111648.
Richards GC. Alcohol-based hand sanitisers: a warning to mitigate future poisonings and deaths. BMJ Evid Based Med. 2021;26:65–8. https://doi.org/10.1136/bmjebm-2020-111568.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was obtained for this study. An Engagement and Dissemination grant (2020) and Seedcorn funding (2021) was obtained from the National Institute of Health Research (NIHR) School for Primary Care Research to develop the Preventable Deaths Tracker website: https://preventabledeathstracker.net/.
Conflicts of Interest/Competing Interests
All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare no support from any organization for the submitted work. HSF has received scholarships (2020–22) from Brasenose College, University of Oxford and Fidelity National Information Services for undergraduate study, from the British Pharmacological Society (2022) for meritorious performance in a research competition and received payments (2022) from Brasenose College, University of Oxford for undergraduate teaching. JKA has published papers in bioscience journals and edited textbooks on adverse drug reactions; he has often acted as an expert witness in civil actions relating to suspected adverse drug reactions and in coroners’ courts. CH holds grant funding from the NIHR, the NIHR School of Primary Care Research. CH has received expenses and fees for his media work, for teaching EBM and is also paid for his GP work in the National Health Service out of hours (contract Oxford Health National Health Service Foundation Trust). CH is the Director of the Centre for Evidence-based Medicine. REF has undertaken research and published on adverse drug reactions and medication errors. REF has acted as an expert witness in coronial and other legal cases related to these. ARC holds grant funding from Cancer Alliance. ARC has received fees for media work, a scientific advisory committee at IQVIA, and external examinations at UK Universities. ARC is the Head of the School of Pharmacy at the University of Birmingham and is an honorary pharmacovigilance pharmacist at the West Midlands Centre for Adverse Drug Reaction Reporting. GCR is the director of a limited company that is independently contracted to work as an epidemiologist and teach at the University of Oxford. GCR received scholarships (2017–20) from the National Health Service NIHR School for Primary Care Research, the Naji Foundation, and the Rotary Foundation to study for a DPhil at the University of Oxford. The study guarantor affirms that the article is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned and registered have been explained.
Ethics Approval
This study exclusively uses publicly available information, for which ethics committee approval is not required.
Consent to Participate
Patient consent was not sought for this study, which exclusively used publicly available information regarding deceased individuals.
Consent for Publication
Not applicable.
Availability of Data and Material
All study materials, data, and statistical code are openly available via online repositories. The study protocol was preregistered on the OSF (https://doi.org/10.17605/OSF.IO/TX3CS); the code to generate the database and the Preventable Deaths Tracker is openly available via GitHub (https://github.com/georgiarichards/georgiarichards.github.io); individual Prevention of Future Deaths reports are available on the Courts and Tribunals Judiciary website (https://www.judiciary.uk/prevention-of-future-death-reports/); and all other study materials are openly available via the OSF project page (https://doi.org/10.17605/OSF.IO/WQ7G5).
Code Availability
The code to generate the database and the Preventable Deaths Tracker is openly available via GitHub (https://github.com/georgiarichards/georgiarichards.github.io).
Author contributions
HSF updated the study protocol, carried out screening of PFDs, extracted remaining data, conducted all analyses, produced all figures and tables, and wrote the first draft of the manuscript. GCR conceptualized, designed, and initiated the study; provided supervisory support, and edited the first draft of the manuscript. REF and ARC contributed to the study conceptualization. CH and JKA provided supervisory support and oversight. REF and JKA provided clinical pharmacological advice and interpretation. All study authors read, contributed to, and approved the final manuscript. HSF is the guarantor. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Additional information
Preprint uploaded to MedRxiv. Available at: https://doi.org/10.1101/2022.11.01.22281803.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
France, H.S., Aronson, J.K., Heneghan, C. et al. Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners’ Reports 2013–22. Drug Saf 46, 335–342 (2023). https://doi.org/10.1007/s40264-023-01274-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40264-023-01274-8